Stay updated on Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial
Sign up to get notified when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.

Latest updates to the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page
- CheckyesterdayChange DetectedA banner announces NIH website updates and a temporary transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.4%

- Check8 days agoChange DetectedThe ClinicalTrials.gov site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check15 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check36 days agoChange DetectedA new revision entry v3.7.0 was added to the Record History, and the previous revision v3.6.6 was removed from the list. This reflects an update to the visible version history of the study record.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry v3.6.6 has been added to the study record history, and the previous revision v3.6.5 has been removed from the list. This reflects an update to the page's version history rather than changes to the study details.SummaryDifference0.1%

- Check78 days agoChange DetectedThe record history now includes a new revision entry (v3.6.5) that supersedes the previous revision (v3.6.4). This indicates a minor update to the study record without altering the substantive content.SummaryDifference0.1%

Stay in the know with updates to Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.